The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Recognition and processing of cisplatin- and oxaliplatin-DNA adducts
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Proceedings of the National Academy of Sciences of the United States of America
Dowling, J. E., & Wald, G. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1981.tb06752.x · Cited by 17,893
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
Jamieson, E. R., & Lippard, S. J. (1999) · Chemical Reviews · doi:10.1021/cr980421n · Cited by 2,949
Mechanisms of resistance to cisplatin
Kartalou, M., & Essigmann, J. M. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00141-5 · Cited by 869
Crystal structures of mismatch repair protein MutS and its complex with a substrate DNA
Obmolova, G., Ban, C., Hsieh, P., & Yang, W. (2000) · Nature · doi:10.1038/35037509 · Cited by 646
The crystal structure of DNA mismatch repair protein MutS binding to a G·T mismatch
Lamers, M. H., Perrakis, A., Enzlin, J. H., Winterwerp, H. H. K., de Wind, N., & Sixma, T. K. (2000) · Nature · doi:10.1038/35037523 · Cited by 633
Eukaryotic polymerases ι and ζ act sequentially to bypass DNA lesions
Johnson, R. E., Washington, M. T., Haracska, L., Prakash, S., & Prakash, L. (2000) · Nature · doi:10.1038/35023030 · Cited by 632
Rixe, O., Ortuzar, W., Alvarez, M., Parker, R., Reed, E., Paull, K., & Fojo, T. (1996) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)81490-6 · Cited by 615
The role of DNA mismatch repair in platinum drug resistance.
Fink, D. A., Nebel, S., Aebi, S. P., Zheng, H., Cenni, B., Nehmé, A., Christen, R. D., & Howell, S. B. (1996) · PubMed · Cited by 597
Sawaya, M. R., Prasad, R., Wilson, S. H., Kraut, J., & Pelletier, H. (1997) · Biochemistry · doi:10.1021/bi9703812 · Cited by 592
Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins
Ohndorf, U.-M., Rould, M. A., He, Q., Pabo, C. O., & Lippard, S. J. (1999) · Nature · doi:10.1038/21460 · Cited by 565
Eastman, A. (1987) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(87)90009-x · Cited by 539
Mechanisms of accurate translesion synthesis by human DNA polymerase η
Masutani, C., Kusumoto, R., Iwai, S., & Hanaoka, F. (2000) · The EMBO Journal · doi:10.1093/emboj/19.12.3100 · Cited by 504
Loss of DNA mismatch repair in acquired resistance to cisplatin.
Aebi, S. P., Kurdi-Haidar, B., Gordon, R. T., Cenni, B., Zheng, H., Fink, D. A., Christen, R. D., Boland, C. R., Koi, M., Fishel, R. A., et al. (1996) · PubMed · Cited by 502
Specific Binding of Chromosomal Protein HMG1 to DNA Damaged by the Anticancer Drug Cisplatin
Pil, P. M., & Lippard, S. J. (1992) · Science · doi:10.1126/science.1566071 · Cited by 496
Xeroderma Pigmentosum Group E Cells Lack a Nuclear Factor That Binds to Damaged DNA
Chu, G., & Chang, E. (1988) · Science · doi:10.1126/science.3175673 · Cited by 416
Crystal Structure of the Anticancer Drug Cisplatin Bound to Duplex DNA
Takahara, P. M., Frederick, C. A., & Lippard, S. J. (1996) · Journal of the American Chemical Society · doi:10.1021/ja9625079 · Cited by 405
Fidelity of Human DNA Polymerase η
Johnson, R. E., Washington, M. T., Prakash, S., & Prakash, L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.7447 · Cited by 400
Low fidelity DNA synthesis by human DNA polymerase-η
Matsuda, T., Bebenek, K., Masutani, C., Hanaoka, F., & Kunkel, T. A. (2000) · Nature · doi:10.1038/35010014 · Cited by 372
Strathdee, G., MacKean, M. J., Illand, M., & Brown, R. (1999) · Oncogene · doi:10.1038/sj.onc.1202540 · Cited by 350
Huang, J. C., Zamble, D. B., Reardon, J. T., Lippard, S. J., & Sancar, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10394 · Cited by 347
MAHER, V. M., OUELLETTE, L. M., CURREN, R. D., & MCCORMICK, J. J. (1976) · Nature · doi:10.1038/261593a0 · Cited by 333
Drummond, J. T., Anthoney, A., Brown, R., & Modrich, P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.19645 · Cited by 295
Vaisman, A., Varchenko, M., Umar, A., Kunkel, T. A., Risinger, J. I., Barrett, J. C., Hamilton, T. C., & Chaney, S. G. (1998) · PubMed · Cited by 294
Self-citationPreferential binding of the xeroderma pigmentosum group A complementing protein to damaged DNA
Jones, C. J., & Wood, R. D. (1993) · Biochemistry · doi:10.1021/bi00096a021 · Cited by 291
Gelasco, A., & Lippard, S. J. (1998) · Biochemistry · doi:10.1021/bi973176v · Cited by 282
Reardon, J. T., Vaisman, A., Chaney, S. G., & Sancar, A. (1999) · PubMed · Cited by 281
Self-citationIn vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair.
Fink, D. A., Zheng, H., Nebel, S., Norris, P. S., Aebi, S. P., Lin, T., Nehmé, A., Christen, R. D., Haas, M., MacLeod, C. L., et al. (1997) · PubMed · Cited by 277
Vaisman, A., Masutani, C., Hanaoka, F., & Chaney, S. G. (2000) · Biochemistry · doi:10.1021/bi000130k · Cited by 211
Self-citationHe, Q., Liang, C. H., & Lippard, S. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100108697 · Cited by 209
Spingler, B., Whittington, D. A., & Lippard, S. J. (2001) · Inorganic Chemistry · doi:10.1021/ic010790t · Cited by 207
Mu, D., Tursun, M., Duckett, D. R., Drummond, J. T., Modrich, P., & Sancar, A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.2.760 · Cited by 198
Simon, J. A., Szankasi, P., Nguyen, D. K., Ludlow, C. L., Dunstan, H. M., Roberts, C. J., Jensen, E. L., Hartwell, L. H., & Friend, S. H. (2000) · PubMed · Cited by 193
Canitrot, Y., Cazaux, C., Fréchet, M., Bouayadi, K., Lesca, C., Salles, B., & Hoffmann, J.-S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12586 · Cited by 192
Biological and clinical importance of the p53 tumor suppressor gene
Velculescu, V. E., & El-Deiry, W. S. (1996) · Clinical Chemistry · doi:10.1093/clinchem/42.6.858 · Cited by 180
Ixr1, a Yeast Protein That Binds to Platinated DNA and Confers Sensitivity to Cisplatin
Brown, S. J., Kellett, P. J., & Lippard, S. J. (1993) · Science · doi:10.1126/science.8342024 · Cited by 178
Cisplatin- and UV-damaged DNA lure the basal transcription factor TFIID/TBP
Vichi, P. (1997) · The EMBO Journal · doi:10.1093/emboj/16.24.7444 · Cited by 172
Selective recognition of a cisplatin-DNA adduct by human mismatch repair proteins
Yamada, M. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.3.491 · Cited by 161
Is Cisplatin a Human Carcinogen?
Greene, M. H. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.5.306 · Cited by 152
Treiber, D. K., Zhai, X., Jantzen, H., & Essigmann, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5672 · Cited by 151
Translesion Synthesis by Human DNA Polymerase η across Thymine Glycol Lesions
Kusumoto, R., Masutani, C., Iwai, S., & Hanaoka, F. (2002) · Biochemistry · doi:10.1021/bi025549k · Cited by 147
Vaisman, A., Lim, S. E., Patrick, S. M., Copeland, W. C., Hinkle, D. C., Turchi, J. J., & Chaney, S. G. (1999) · Biochemistry · doi:10.1021/bi9909187 · Cited by 140
Self-citationEffect of the diaminocyclohexane carrier ligand on platinum adduct formation, repair, and lethality
Page, J. D., Husain, I., Sancar, A., & Chaney, S. G. (1990) · Biochemistry · doi:10.1021/bi00456a026 · Cited by 139
Self-citationWu, H. I., Brown, J. M., Dorie, M. J., Lazzeroni, L. C., & Brown, J. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3113 · Cited by 138
Xeroderma pigmentosum group E binding factor recognizes a broad spectrum of DNA damage
Payne, A. S., & Chu, G. (1994) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(94)90012-4 · Cited by 132
Nehmé, A., Baskaran, R., Aebi, S. P., Fink, D. A., Nebel, S., Cenni, B., Wang, J. Y. J., Howell, S. B., & Christen, R. D. (1997) · PubMed · Cited by 129
Samimi, G., Fink, D. A., Varki, N. M., Husain, A., Hoskins, W. J., Alberts, D. S., & Howell, S. B. (2000) · PubMed · Cited by 128
Nehmé, A., Baskaran, R., Nebel, S., Fink, D. A., Howell, S. B., Wang, J. Y. J., & Christen, R. D. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690176 · Cited by 126
Mutagenic and carcinogenic properties of platinum-based anticancer drugs
Sanderson, B. J. S., Ferguson, L. R., & Denny, W. A. (1996) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(96)00022-x · Cited by 125
Haracska, L., Prakash, S., & Prakash, L. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.4.1453-1459.2003 · Cited by 123
Marzilli, L. G., Saad, J. S., Kuklenyik, Z., Keating, K. A., & Xu, Y. (2001) · Journal of the American Chemical Society · doi:10.1021/ja0007915 · Cited by 113
Lesion bypass in yeast cells: Pol η participates in a multi‐DNA polymerase process
Bresson, A., & Fuchs, R. P. P. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf363 · Cited by 112
The Role of DNA Polymerase η in Translesion Synthesis Past Platinum–DNA Adducts in Human Fibroblasts
Bassett, E., King, N. M., Bryant, M. F., Hector, S., Pendyala, L., Chaney, S. G., & Cordeiro‐Stone, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1328 · Cited by 111
Self-citationCharacterization of adducts produced in DNA by isomeric 1,2-diaminocyclohexaneplatinum(II) complexes
Jennerwein, M. M., Eastman, A. R., & Khokhar, A. (1989) · Chemico-Biological Interactions · doi:10.1016/0009-2797(89)90061-6 · Cited by 104
MutS Preferentially Recognizes Cisplatin- over Oxaliplatin-modified DNA
Zdraveski, Z. Z., Mello, J. A., Farinelli, C. K., Essigmann, J. M., & Marinus, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105382200 · Cited by 103
The HMG-domain protein Ixr1 blocks excision repair of cisplatin-DNA adducts in yeast
McA'Nulty, M. M., & Lippard, S. J. (1996) · Mutation Research/DNA Repair · doi:10.1016/0921-8777(95)00037-2 · Cited by 102
Zhai, X., Beckmann, H., Jantzen, H., & Essigmann, J. M. (1998) · Biochemistry · doi:10.1021/bi981708h · Cited by 100
Patrick, S. M., & Turchi, J. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.21.14972 · Cited by 99
Mechanisms of drug resistance in ovarian cancer
Johnson, S. W., Ozols, R. F., & Hamilton, T. C. (2010) · Cancer · doi:10.1002/cncr.2820710224 · Cited by 99
Vaisman, A., & Chaney, S. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.17.13017 · Cited by 97
Self-citationBergoglio, V., Canitrot, Y., Hogarth, L., Minto, L., Howell, S. B., Cazaux, C., & Hoffmann, J. (2001) · Oncogene · doi:10.1038/sj.onc.1204743 · Cited by 92
Clugston, C. K., McLaughlin, K., Kenny, M. K., & Brown, R. E. (1992) · PubMed · Cited by 90
Recognition of distorted DNA structures by HMG domains
TRAVERS, A. A. (2000) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(99)00056-1 · Cited by 88
Testis-specific HMG-domain protein alters the responses of cells to cisplatin
Zamble, D. B., Mikata, Y., Eng, C. H., Sandman, K. E., & Lippard, S. J. (2002) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(02)00472-5 · Cited by 83
Wei, M., Cohen, S. M., Silverman, A. P., & Lippard, S. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106374200 · Cited by 79
Spectrum of cisplatin-induced mutations in Escherichia coli.
Burnouf, D., Duane, M. P., & Fuchs, R. P. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.11.3758 · Cited by 78
Trimmer, E. E., Zamble, D. B., Lippard, S. J., & Essigmann, J. M. (1998) · Biochemistry · doi:10.1021/bi971675q · Cited by 78
Zhang, Y., Wu, X., Guo, D., Rechkoblit, O., Geacintov, N. E., & Wang, Z. (2002) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(02)00249-x · Cited by 78
Accuracy of lesion bypass by yeast and human DNA polymerase η
Washington, M. T., Johnson, R. E., Prakash, L., & Prakash, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121007298 · Cited by 71
Specificity of platinum–DNA adduct repair
Chaney, S. G., & Vaisman, A. (1999) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(99)00149-x · Cited by 69
Self-citationNMR Solution Structure of an Oxaliplatin 1,2-d(GG) Intrastrand Cross-link in a DNA Dodecamer Duplex
Wu, Y., Pradhan, P., Havener, J. M., Boysen, G., Swenberg, J. A., Campbell, S. L., & Chaney, S. G. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.06.066 · Cited by 66
Self-citationTurchi, J. J., & Henkels, K. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.23.13861 · Cited by 66
Beljanski, V., Marzilli, L. G., & Doetsch, P. W. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.6.1496 · Cited by 66
Human Replication Protein A Preferentially Binds Cisplatin-Damaged Duplex DNA in Vitro
Patrick, S. M., & Turchi, J. J. (1998) · Biochemistry · doi:10.1021/bi9730590 · Cited by 63
The major chromatin protein histone H1 binds preferentially to cis -platinum-damaged DNA
Yaneva, J. N., Leuba, S. H., Holde, K. V., & Zlatanova, J. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13448 · Cited by 60
Fourrier, L., Brooks, P., & Malinge, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301390200 · Cited by 57
Sequence specificity of mutation induced by the anti-tumor drug cisplatin in the CHO aprt gene
de Boer, J. G., & Glickman, B. W. (1989) · Carcinogenesis · doi:10.1093/carcin/10.8.1363 · Cited by 55
Bubley, G. J., Ashburner, B. P., & Teicher, B. A. (1991) · Molecular Carcinogenesis · doi:10.1002/mc.2940040512 · Cited by 48
Bassett, E., Vaisman, A., Leeman, K. T., McCall, C. M., Masutani, C., Hanaoka, F., & Chaney, S. G. (2002) · DNA repair · doi:10.1016/s1568-7864(02)00150-7 · Cited by 48
Self-citationBinding of Ixr1, a Yeast HMG-Domain Protein, to Cisplatin−DNA Adducts in Vitro and in Vivo
McA'Nulty, M. M., Whitehead, J. P., & Lippard, S. J. (1996) · Biochemistry · doi:10.1021/bi952877u · Cited by 47
Coin, F., Frit, P., Viollet, B., Salles, B., & Egly, J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.3907 · Cited by 45
Lin, X., & Howell, S. B. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.2.390 · Cited by 45
Cisplatin Sensitivity in Hmgb1−/− and Hmgb1+/+ Mouse Cells
Wei, M., Burenkova, O. V., & Lippard, S. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210562200 · Cited by 44
Hoffmann, J., Locker, D., Villani, G., & Leng, M. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1143 · Cited by 41
Reduced MLH1 expression after chemotherapy is an indicator for poor prognosis in esophageal cancers.
Kishi, K., Doki, Y., Yano, M., Yasuda, T., Fujiwara, Y., Takiguchi, S., Kim, S., Higuchi, I., & Monden, M. (2003) · PubMed · Cited by 41
HIV-1 Tat increases cell survival in response to cisplatin by stimulating Rad51 gene expression
Chipitsyna, G. I., Słonina, D., Siddiqui, K. M., Peruzzi, F., Skórski, T., Krzysztof Reiss, F., Sawaya, B. E., Khalili, K., & Amini, S. (2004) · Oncogene · doi:10.1038/sj.onc.1207417 · Cited by 40
Translesion Synthesis Past Platinum DNA Adducts by Human DNA Polymerase μ
Havener, J. M., McElhinny, S. A. N., Bassett, E., Gauger, M. A., Ramsden, D. A., & Chaney, S. G. (2003) · Biochemistry · doi:10.1021/bi0270079 · Cited by 40
Self-citationPétersen, L. N., Mamenta, E. L., Stevnsner, T., Chaney, S. G., & Bohr, V. A. (1996) · Carcinogenesis · doi:10.1093/carcin/17.12.2597 · Cited by 37
Self-citationVaisman, A., Warren, M. W., & Chaney, S. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007805200 · Cited by 35
Self-citationp53 binds to cisplatin-damaged DNA
Wetzel, C. C., & Berberich, S. J. (2001) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(00)00305-5 · Cited by 34
Loss of hMLH1 expression correlates with improved survival in stage III–IV ovarian cancer patients
Scartozzi, M., Nictolis, M. D., Galizia, G., Carassai, P., Bianchi, F., Berardi, R., Gesuita, R., Piga, A., Cellerino, R., & Porfiri, E. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00197-7 · Cited by 33
Kinetic Studies of the TATA-binding Protein Interaction with Cisplatin-modified DNA
Jung, Y., Mikata, Y., & Lippard, S. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108299200 · Cited by 33
van Waardenburg, R. C. A. M., de Jong, L. A., van Delft, F., van Eijndhoven, M. A. J., Bohlander, M., Bjornsti, M., Brouwer, J., & Schellens, J. H. M. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.393.3.4 · Cited by 27
Cordeiro‐Stone, M., Boyer, J. C., Smith, B. A., & Kaufmann, W. K. (1986) · Carcinogenesis · doi:10.1093/carcin/7.10.1783 · Cited by 14
Cited by
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
Florea, A.-M., & Büsselberg, D. (2011) · Cancers · doi:10.3390/cancers3011351 · Cited by 1,759
DNA damage-induced cell death by apoptosis
Roos, W. P., & Kaina, B. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.07.007 · Cited by 1,500
Direct Cellular Responses to Platinum-Induced DNA Damage
Jung, Y., & Lippard, S. J. (2007) · Chemical Reviews · doi:10.1021/cr068207j · Cited by 1,391
Mechanisms of resistance to cisplatin and carboplatin
Stewart, D. J. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.02.001 · Cited by 631
Metadata
- Authors
- Chaney, S. G., Campbell, S. L., Bassett, E., & Wu, Y.
- Venue
- Critical Reviews in Oncology/Hematology
- Publisher
- Elsevier BV
- Published
- 2005-01
- Volume
- 53
- Issue
- 1
- Pages
- 3-11
- ISSN
- 1040-8428 (ISSN-L)
- OpenAlex
- W2146497129
- Cited by
- 396
- References
- 93
- FWCI
- 4.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.